Monsanto Corp's G.D. Searle Co unit report operating loss 1987 mainly due expense research development. Searle chairman Sheldon Gilgore Searle's operating loss 1987 87 mln dlr operating loss 1986. He Searle's quarter sale 21.8 pct 179 mln dlrs 147 mln dlrs ago quarter. In 1986 Searle's sale 665 mln dlrs. Gilgore company intend sale billion dlrs mid-1990s. He company anticipates approval Japan U.S. Italy Spain U.K. ulcer treatment drug Cytotech. He paper yet publish drug show prevent flare-up ulcer longer period Tagamet SmithKline Beckman Corp SKB>. Other drug Searle's pipeline include tissue plasminogen activator (TPA) process Genentech's GENE> TPA expect approve marketing year. Reuter 